Porcilis Pesti

Withdrawn

This medicine's authorisation has been withdrawn

adjuvanted vaccine against classical swine fever

Overview

The marketing authorisation for Porcilis Pesti has been withdrawn at the request of the marketing authorisation holder

Porcilis Pesti : EPAR - Summary for the public

Product information

Porcilis Pesti : EPAR - Product Information

Porcilis Pesti : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Porcilis Pesti
• Active substance:
  Classical Swine Fever Virus (CSFV) -E2 subunit antigen
• International non-proprietary name (INN) or common name:
  adjuvanted vaccine against classical swine fever
• Species:
  Pigs
• Anatomical therapeutic chemical veterinary (ATCvet) code:
  QI09AD04

Pharmacotherapeutic group

Immunologicals for suidae

Therapeutic indication

Active immunisation of pigs from the age of 5 weeks onwards to prevent mortality and to reduce clinical signs of Classical Swine Fever, as well as to reduce infection with and excretion of CSF field virus.
The onset of protection is 2 weeks.
The duration of protection is 6 months.

Authorisation details

• EMA product number:
  EMEA/V/C/000046
• Marketing authorisation holder:
  Intervet International BV

  Wim de Körverstraat 35; 5831 AN Boxmeer; The Netherlands

• Marketing authorisation issued:
  09/06/2000
• Revision:
  12

Assessment history

Changes since initial authorisation of medicine

Porcilis Pesti : EPAR - Procedural steps taken and scientific information after authorisation

Initial marketing authorisation documents

Porcilis Pesti : EPAR - Scientific Discussion

Porcilis Pesti : EPAR - Procedural steps taken before authorisation